GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial win
GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug [...]
AstraZeneca’s star China business slows on Tagrisso price cut, but Alexion may come to the rescue
AstraZeneca’s star China business slows on Tagrisso price cut, but [...]
Johnson & Johnson to spin out consumer health business in new publicly traded company
Johnson & Johnson to spin out consumer health business in [...]
Fierce Pharma Asia—Takeda’s Alunbrig pricing pact; Merck, Japan COVID pill deal; SK Biopharm’s Chinese JV
Fierce Pharma Asia—Takeda’s Alunbrig pricing pact; Merck, Japan COVID pill [...]
AstraZeneca’s latest heart awareness campaign with fitness guru Bob Harper showcases his passion for photography
AstraZeneca’s latest heart awareness campaign with fitness guru Bob Harper [...]
Late to the party: Europe on the verge of approving Roche and Celltrion antibodies for COVID
Late to the party: Europe on the verge of approving [...]
Biogen posts more Aduhelm biomarker data and a ‘correlation’ with Alzheimer’s clinical benefit
Biogen posts more Aduhelm biomarker data and a ‘correlation’ with [...]
Despite strong efficacy, dermatologist survey indicates Incyte’s Opzelura uptake may face uphill climb: report
Despite strong efficacy, dermatologist survey indicates Incyte’s Opzelura uptake may [...]
Lundbeck cuts 300 jobs to fuel Vyepti growth as CGRP migraine competition heats up
Lundbeck cuts 300 jobs to fuel Vyepti growth as CGRP [...]
Johnson & Johnson scores 60-day stay in high-profile talc litigation: report
Johnson & Johnson scores 60-day stay in high-profile talc litigation: [...]